Showing 111-120 of 806 results for "".
Atypical Sweet Syndrome: A Case Report and Brief Literature Review
https://practicaldermatology.com/topics/rare-disease/atypical-sweet-syndrome-a-case-report-and-brief-literature-review/23610/A case highlights the complexity of this diagnosis, including its management and workup, especially when pathology findings are atypical.Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.Teledermatology: The Present State of Dermatology's Future
https://practicaldermatology.com/topics/practice-management/teledermatology-the-present-state-of-dermatologys-future/21439/Business Advisor: Before/After Pictures Are Worth More Than Words to Aesthetic Practices
https://practicaldermatology.com/topics/general-topics/business-advisor-beforeafter-pictures-are-worth-more-than-words-to-aesthetic-practices/21887/High-quality before and after pictures are a necessity in today's competitive marketplace. Make an investment in equipment and in training yourself and your staff.Currents
https://practicaldermatology.com/topics/practice-management/currents/21012/DermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-acneally-launches-rosacea-insights-mc2epi-collaboration/19849/Dennis Porto, MD and Riyaz Farhaad, MD have launched AcneAlly.com, an online service that allows patients access to a board certified dermatologist and a standardized approach to assessment and long-term monitoring. Julie Harper, MD discusses findings from “Beyond the visible: Rosacea and psoriasisGalderma's Future, Allergan's Bonti Buy, and Sebacia Clearance
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-galderma-s-future-allergan-s-bonti-buy-and-sebacia-clearance--xgheloga/18233/Nestle's Board says it has come to the conclusion that the future growth opportunities of Nestlé Skin Health lie increasingly outside the Group's strategic scope and expects a review of strategic options for Nestlé Skin Health to be complete by mid-2019. Allergan is acquiring Bonti for 195 million dA Case of Pemphigus Foliaceus
https://practicaldermatology.com/topics/infections-infectious-disease/a-case-of-pemphigus-foliaceus/23156/A case-based discussion of an immunobullous disorder.Open Payments Program: Does it Enhance Open Discussion About Financial Ties Between Dermatologists and Industry?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/open-payments-program-does-it-enhance-open-discussion-about-financial-ties-between-dermatologists-and-industry/23619/The majority of physicians practicing in the United States have received some form of compensation from private industry during their careers. These payments may include consulting fees, compensation for speaking engagements, and stock options. Certain payments take indirect forms, such as physicMelanoma and the Predictive Value of Nevi: Unexpected Findings?
https://practicaldermatology.com/topics/practice-management/melanoma-and-the-predictive-value-of-nevi-unexpected-findings/20936/A new analysis shows that the association between nevi and melanoma is complex.